IMMUNOGLOBULIN FC CONJUGATE WHICH MAINTAINS BINDING AFFINITY OF IMMUNOGLOBULIN FC FRAGMENT TO FCRN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160152684A1
SERIAL NO

14904543

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a physiologically active polypeptide-immunoglobulin Fc fragment conjugate, which comprises a physiologically active polypeptide linked via a non-peptidyl linker to an immunoglobulin Fc fragment having an FcRn-binding region and maintains the intrinsic binding affinity of the immunoglobulin Fc fragment, a method for preparing the conjugate, a method of maintaining the intrinsic binding affinity of the conjugate for FcRn, and a composition comprising the conjugate, which maintains the intrinsic binding affinity of the immunoglobulin Fc fragment for FcRn.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANMI PHARM CO LTDHWASEONG-SI GYEONGGI-DO 18536

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHOI, In Young Yongin-si, KR 65 461
HONG, Sung Hee Suwon-si, KR 77 198
HWANG, Sang Youn Hwaseong-si, KR 13 52
JUNG, Sung Youb Suwon-si, KR 86 704
KWON, Se Chang Seoul, KR 120 1146
LEE, Jong Soo Seongnam-si, KR 85 376

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation